ZSHK Debuts in 2022 ShenZhen International Biotech & Health Industry Expo and BT Summit
Date 2022-11-08 16:58
Author:admin
In 3
rd to 4
th November 2022, ShenZhen, China, ZSHK Laboratories Limited (ZSHK) and its wholly-owned subsidiaries—Anling Biomed (Shenzhen) Co. ,Ltd. (Anling (Shenzhen)) and Anling Biomed (Suzhou) Co. ,Ltd. (Anling (Suzhou)) were invited to 2022 Shenzhen International Biopharmaceutical Industry Innovation & Development Summit and debuts in 2022 ShenZhen International Biotech & Health Industry Expo with booth settled in B14, and a recruitment booth settled in B14 of high-end talent recruitment area. The event was crowned with complete success and has gained wide attention and positive feedbacks from government officials, clients of the industry, high-end talents and friends from the media!
Such event was organized in the form of “summit combining with expo”, which is a crucial window for exhibiting the development level of biopharmaceutical industry. The booth of ZSHK and its wholly owned subsidiaries had attracted countless of visitors. Staffs had always remained fully passionate when communicating with visitors. Professional visitors and participated exhibitors expressed their great interest in cooperating with us after a further insight into our company. Jin Yi—GM of Anling (Shenzhen) has come to our company’s booth to instruct our staff members and was interviewed by the media to express his determination in promoting the development of biopharmaceutical industry.
By participating in such event, we interchanged and learned with one another with experts and professors of the industry deeply, widened our horizons, and revealed our company’s comprehensive strength. We collected information of potential clients through on-cite communication and further understood the latest market conditions and demand of clients. ZSHK is also looking forward to assisting more biopharmaceutical enterprises in faster and better development to support the industry, offer core engine to the innovation of bio-health industry, pay an effort to the development of biopharmaceutical business of Greater Bay Area and even to the whole country and globe.